Radnostix 

$0.08
2
+$0+3.37% Thursday 17:55

Statistics

Day High
0.08
Day Low
0.08
52W High
0.11
52W Low
0.03
Volume
1,000
Avg. Volume
35,001
Mkt Cap
43.68M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
-0
0
0
0
Expected EPS
N/A
Actual EPS
N/A

Financials

0.06%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
27.8MRevenue
18,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INIS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BWX Technologies
BWXT
Mkt Cap19.52B
BWX Technologies, Inc. provides nuclear components and fuel for the U.S. government, also offering isotopes for medical and industrial applications.
CPS Technologies
CPSH
Mkt Cap71.38M
CPS Technologies Corp. manufactures advanced material solutions, including components for nuclear reactors, indirectly competing in the nuclear technology sector.
Lightbridge
LTBR
Mkt Cap800.61M
Lightbridge Corporation is involved in the development of nuclear fuel technology, which could be seen as a competitor in the broader nuclear sector.
Uranium Royalty
UROY
Mkt Cap653.74M
Uranium Royalty Corp. focuses on uranium investments, indirectly competing by influencing the uranium market, which is crucial for nuclear medicine and isotopes.
Denison Mines
DNN
Mkt Cap2.87B
Denison Mines Corp. is engaged in uranium mining and exploration, indirectly affecting the supply chain for nuclear medicine and isotope production.
Ur-Energy
URG
Mkt Cap647.09M
Ur-Energy Inc. operates as a uranium mining company, indirectly competing through its role in the uranium market, impacting the nuclear sector.
Uranium Energy
UEC
Mkt Cap7.31B
Uranium Energy Corp. is a uranium mining and exploration company, indirectly competing by contributing to the uranium supply necessary for isotope production.
Cameco
CCJ
Mkt Cap44.63B
Cameco Corporation is one of the largest global providers of the uranium needed to produce nuclear energy and isotopes, indirectly competing in the supply chain.
Centrus Energy
LEU
Mkt Cap6.69B
Centrus Energy Corp. supplies enriched uranium for nuclear power, indirectly competing in the nuclear energy sector, which overlaps with isotope production.

About

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through five segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. It sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
Show more...
CEO
Mr. Shahe Bagerdjian
Employees
41
Country
US
ISIN
US45972C1027

Listings

0 Comments

Share your thoughts

FAQ

What is Radnostix stock price today?
The current price of INIS is $0.08 USD — it has increased by +3.37% in the past 24 hours. Watch Radnostix stock price performance more closely on the chart.
What is Radnostix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Radnostix stocks are traded under the ticker INIS.
Is Radnostix stock price growing?
INIS stock has risen by +8.67% compared to the previous week, the month change is a -8.11% fall, over the last year Radnostix has showed a +94.59% increase.
What is Radnostix market cap?
Today Radnostix has the market capitalization of 43.68M
What is Radnostix revenue for the last year?
Radnostix revenue for the last year amounts to 27.8M USD.
What is Radnostix net income for the last year?
INIS net income for the last year is 18,000 USD.
How many employees does Radnostix have?
As of April 03, 2026, the company has 41 employees.
In which sector is Radnostix located?
Radnostix operates in the Health Care sector.
When did Radnostix complete a stock split?
Radnostix has not had any recent stock splits.
Where is Radnostix headquartered?
Radnostix is headquartered in Idaho Falls, US.